Cme Group Inc. CME

Revenue Intelligence Report • 70 quarters of SEC filing data • Updated 2026-03-15

CME Group's revenue is expected to grow about 6% year over year to roughly $7.3 billion, driven by platform scale and pricing power rather than incremental SG&A spend. The binding constraint on revenue growth appears to be platform capacity—trading and clearing throughput—as our econometric model shows structural growth accounting for about 93% of the rise while SG&A contributes roughly 7%. The time-varying SG&A multiplier has fallen from about 1.12 to -0.04 over the period, indicating rising operating leverage and that CME can generate more revenue without a proportional increase in spend. Key risk: a surge in volumes beyond system capacity could throttle growth, making trading and clearing capacity the critical constraint to monitor.

Investment Thesis

The econometric model achieves strong accuracy (5.8% MAPE), suggesting Cme Group Inc.'s revenue trajectory is well-characterized by its spending patterns. Each $1 of SG&A spending generates $2.53 in revenue, reflecting strong commercial efficiency.

Next FY Revenue
$6.93B
+6.2% YoY
SG&A Multiplier
$2.53 per $1
Model Accuracy
5.8% MAPE
Holdout validation: The model predicted $1.6B vs the actual $1.6B — an error of 0.2%.
Note: Cme Group Inc. does not report R&D expenses separately. This analysis uses SG&A spending only.

Revenue Forecast

CME Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $1.6B $1.6B $1.5B – $1.8B +7.8% ✓ In range
Q2 2026 $1.7B $1.5B – $2.0B +4.7%
Q3 2026 $1.7B $1.4B – $2.0B +2.1%
Q4 2026 $1.7B $1.4B – $2.0B +10.6%
Q1 2027 $1.8B $1.4B – $2.1B +7.9%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Cme Group Inc.'s systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 0.9702 -3.0% In line with trend 17
FQ2 (Dec–Feb) 0.9781 -2.2% In line with trend 17
FQ3 (Mar–May) 1.0365 +3.6% +3.6% above trend 16
FQ4 (Jun–Aug) 1.0141 +1.4% In line with trend 16

How Spending Drives Revenue

CME Spending Timing
Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Spending Efficiency Over Time

Time-varying analysis: A penalized spline model (GAM) tracks how the link between spending and revenue has evolved over 70 quarters. A rising multiplier means each dollar of spending drives more revenue over time, signaling improving efficiency. A falling multiplier can indicate market saturation or rising cost-to-acquire.
Current SG&A multiplier: -0.0426

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch